ArticleJournal of translational medicine2017

Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo.

Ditte Reker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.